SRTS vs. SKIN, ZIMV, BSGM, SNWV, DRTS, NYXH, SMTI, CATX, BWAY, and TCMD
Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), Sanuwave Health (SNWV), Alpha Tau Medical (DRTS), Nyxoah (NYXH), Sanara MedTech (SMTI), Perspective Therapeutics (CATX), Brainsway (BWAY), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry.
Sensus Healthcare vs. Its Competitors
Sensus Healthcare (NASDAQ:SRTS) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.
Sensus Healthcare currently has a consensus price target of $11.67, suggesting a potential upside of 177.78%. Beauty Health has a consensus price target of $1.42, suggesting a potential downside of 13.62%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sensus Healthcare is more favorable than Beauty Health.
In the previous week, Beauty Health had 17 more articles in the media than Sensus Healthcare. MarketBeat recorded 19 mentions for Beauty Health and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.94 beat Beauty Health's score of 0.83 indicating that Sensus Healthcare is being referred to more favorably in the media.
Sensus Healthcare has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500.
25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 8.9% of Sensus Healthcare shares are held by company insiders. Comparatively, 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Sensus Healthcare has a net margin of 4.56% compared to Beauty Health's net margin of -11.94%. Sensus Healthcare's return on equity of 3.34% beat Beauty Health's return on equity.
Sensus Healthcare has higher earnings, but lower revenue than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
Summary
Sensus Healthcare beats Beauty Health on 12 of the 16 factors compared between the two stocks.
Get Sensus Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sensus Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:SRTS) was last updated on 7/16/2025 by MarketBeat.com Staff
Free SRTS Stock Alerts